In this study, we provide serologic evidence demonstrating that EBV reactivation not only correlates with the presence of SLE but also high disease activity and elevated levels of the soluble mediators IP-10, IL-10, and BLyS. Here, CXCL10 is linked to systemic lupus erythematosus.